Clinical Trials List
Protocol Number111443 , 111470, 111471, 111472
2008-03-01 - 2011-05-30
Phase III
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shan-Chwen Chang Division of General Internal Medicine
- 林明澤 Division of General Internal Medicine
- Szu-Min Hsieh Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- CHUN-TA HUANG Division of General Internal Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- 林佩瑩 Division of General Internal Medicine
- 樹金忠 Division of General Internal Medicine
- 吳則樂 Division of General Internal Medicine
- 巫震宇 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林明憲 Division of Family Medicine
- Tzeng-Ji Chen Division of Family Medicine
- 謝世良 Division of Rheumatology
- Liang-Kung Chen Division of Family Medicine
- 劉瑞瑤 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
276 participants
-
Global
947 participants
